Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|June 6, 2017
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA MutationMark Robson, Seock-Ah Im, Elżbieta Senkus, et al.
Breast Cancer Research and Treatment|January 12, 2011
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriersKelly Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
Gynecologic Oncology|December 14, 2004
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriersKelly A Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
Hereditary Cancer in Clinical Practice|March 13, 2010
Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation CarriersKelly A Metcalfe, William D Foulkes, Henry T Lynch, et al.
Clinical Genetics|December 13, 2021
The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delTAmy Finch, Kelly Metcalfe, Mohammad Akbari, et al.
JAMA Oncology|August 14, 2015
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk AssessmentAndrea Desmond, Allison W Kurian, Michele Gabree, et al.
Cancer Discovery|May 26, 2012
Evolutionary pathways in BRCA1-associated breast tumorsFilipe C Martins, Subhajyoti De, Vanessa Almendro, et al.
Menopause (New York, N.Y.)|October 24, 2019
Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?Joanne Kotsopoulos, Jacek Gronwald, Jan Lubinski, et al.
International Journal of Cancer|December 9, 2014
Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, et al.
Cancer|April 14, 2019
Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinomaMary Linton B Peters, Lindsey Stobie, Beth Dudley, et al.
Pageof 19